GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OSTO:CEVI) » Definitions » Total Operating Expense

CellaVision AB (OSTO:CEVI) Total Operating Expense : kr297.4 Mil (TTM As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is CellaVision AB Total Operating Expense?

CellaVision AB's Total Operating Expense for the three months ended in Mar. 2024 was kr73.2 Mil. CellaVision AB's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was kr297.4 Mil.


CellaVision AB Total Operating Expense Historical Data

The historical data trend for CellaVision AB's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellaVision AB Total Operating Expense Chart

CellaVision AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 210.16 202.77 229.57 280.05 295.99

CellaVision AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.83 72.64 78.16 73.37 73.25

CellaVision AB Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr297.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellaVision AB Total Operating Expense Related Terms

Thank you for viewing the detailed overview of CellaVision AB's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


CellaVision AB (OSTO:CEVI) Business Description

Traded in Other Exchanges
Address
Mobilvagen 12, Lund, SWE, 22362
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers.

CellaVision AB (OSTO:CEVI) Headlines

No Headlines